ALI R. REZAI, MD
Medical Practice in Columbus, OH
License number
Ohio 35077805
Category
Medical Practice
Type
Neurological Surgery
Address
Address
410 Doan, Columbus, OH 43210
Phone
(614) 293-8714
(614) 293-4281 (Fax)
(614) 293-4281 (Fax)
Personal information
See more information about ALI R. REZAI at radaris.comName
Address
Phone
13900 S Park Blvd, Cleveland, OH 44120
1 Miranova Pl, Columbus, OH 43215
28 Haskell Dr, Cleveland, OH 44108
Cleveland, OH
13900 Park St, Shaker Heights, OH 44120
Professional information
Dr. Ali R Rezai, Columbus OH - MD (Doctor of Medicine)
Specialties:
Neurosurgery
Address:
Neurological Surgery
410 W 10Th Ave, Columbus 43210
(614) 293-8714 (Phone), (614) 293-4024 (Fax)
410 W 10Th Ave, Columbus 43210
(614) 293-8714 (Phone), (614) 293-4024 (Fax)
Certifications:
Neurosurgery, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Neurological Surgery
410 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
410 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Keck School Of Medicine Of The Univ Of Southern California
Graduated: 1990
Keck School Of Medicine Of The Univ Of Southern California
Graduated: 1990
Ali R Rezai, Columbus OH
Specialties:
Neurosurgeon
Address:
410 W 10Th Ave, Columbus, OH 43210
Education:
Doctor of Medicine
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery
Neuromodulatory Method For Treating Chronic Or Refractory Rhinitis
US Patent:
2013027, Oct 17, 2013
Filed:
Apr 17, 2013
Appl. No.:
13/864491
Inventors:
Ali R. Rezai - Columbus OH, US
International Classification:
A61N 1/36, A61N 1/05
US Classification:
607 62, 607118
Abstract:
One aspect of the present disclosure includes a method for treating chronic or refractory rhinitis in a subject. One step of the method includes implanting a therapy delivery system in the subject so that at least one therapy delivery component of the system is positioned substantially adjacent a target location where modulation of the autonomic nervous system (ANS) is effective to treat chronic or refractory rhinitis. The therapy delivery component includes at least one electrode configured to deliver electric current to the target location. Next, electric current is delivered to the at least one electrode to effect a change in the ANS.
Electrical Stimulation Of The Sympathetic Nerve Chain
US Patent:
2013001, Jan 10, 2013
Filed:
Aug 28, 2012
Appl. No.:
13/596241
Inventors:
Ali R. Rezai - Columbus OH, US
Assignee:
The Cleveland Clinic Foundation - Cleveland OH
International Classification:
A61N 1/05, A61N 1/36
US Classification:
607 42, 607116
Abstract:
The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected.
Electrical Stimulation Of The Sympathetic Nerve Chain
US Patent:
2014005, Feb 20, 2014
Filed:
Oct 28, 2013
Appl. No.:
14/064447
Inventors:
Ali R. Rezai - Columbus OH, US
Assignee:
THE CLEVELAND CLINIC FOUNDATION - Cleveland OH
International Classification:
A61N 1/36
US Classification:
607 45
Abstract:
The present invention provides a method of effecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of effecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been effected.
Electrical Stimulation Of The Sympathetic Nerve Chain
US Patent:
2013001, Jan 17, 2013
Filed:
Aug 28, 2012
Appl. No.:
13/596284
Inventors:
Ali R. Rezai - Columbus OH, US
Assignee:
THE CLEVELAND CLINIC FOUNDATION - Cleveland OH
International Classification:
A61N 1/36, A61N 1/05
US Classification:
607 46, 607116
Abstract:
The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected.
Devices, Systems, And Methods For Modulating Uterine Function
US Patent:
2014006, Mar 6, 2014
Filed:
Aug 27, 2013
Appl. No.:
14/011205
Inventors:
Edward Funai - New Albany OH, US
Ali R. Rezai - Columbus OH, US
Ali R. Rezai - Columbus OH, US
Assignee:
Ohio State Innovation Foundation - Columbus OH
International Classification:
A61K 38/48, A61K 38/00, A61N 1/36, A61N 2/00, A61N 1/05, A61K 35/12, A61K 31/7088
US Classification:
424 937, 424 9467, 514 177, 514 44 R, 600 9, 607117, 607 62
Abstract:
One aspect of the present disclosure relates to a method for modulating uterine function in a mammal. One step of the method includes placing a therapy delivery device into direct contact with a spinal cord target associated with uterine function. Next, the therapy delivery device is activated to deliver a therapy signal to the spinal cord target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity in the mammal and thereby modulate uterine function.
Methods And Systems For Treating Acute Heart Failure By Neuromodulation
US Patent:
2014007, Mar 13, 2014
Filed:
Nov 20, 2013
Appl. No.:
14/085311
Inventors:
Marc PENN - Beachwood OH, US
Ali R. REZAI - Columbus OH, US
Ali R. REZAI - Columbus OH, US
Assignee:
Cardionomic - Blaine MN
International Classification:
A61N 1/362, A61M 5/142
US Classification:
604523, 607 62
Abstract:
Methods of treating acute heart failure in a patient in need thereof. Methods include inserting a therapy delivery device into a pulmonary artery of the patient and applying a therapy signal to autonomic cardiopulmonary fibers surrounding the pulmonary artery. The therapy signal affects heart contractility more than heart rate. Specifically, the application of the therapy signal increases heart contractility and treats the acute heart failure in the patient. The therapy signal can include electrical or chemical modulation.
Electrical Stimulation Of The Sympathetic Nerve Chain
US Patent:
2013012, May 16, 2013
Filed:
Jan 4, 2013
Appl. No.:
13/734046
Inventors:
Ali R. Rezai - Columbus OH, US
Assignee:
THE CLEVELAND CLINIC FOUNDATION - Cleveland OH
International Classification:
A61N 1/05, A61N 1/36
US Classification:
607 40, 607118
Abstract:
The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected.
Apparatus, Systems, And Methods For Treating Body Organ Aging
US Patent:
2014008, Mar 20, 2014
Filed:
Sep 19, 2013
Appl. No.:
14/031726
Inventors:
Ali R. Rezai - Columbus OH, US
Assignee:
Ohio State Innovation Foundation - Columbus OH
International Classification:
A61N 1/36
US Classification:
607 62, 607115
Abstract:
One aspect of the present disclosure relates to a method for treating body organ aging in a mammal. One step of the method includes identifying at least one target organ in need of a therapy signal. Next, a therapy delivery device is placed into electrical communication with an autonomic nervous system (ANS) nerve target and/or a central nervous system (CNS) nerve target associated with the at least one target organ. The therapy delivery device is then activated to deliver the therapy signal to the ANS nerve target and/or the CNS nerve target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity associated with the at least one target organ.